Skip to main content
. 2022 May 11;18(5):e780–e785. doi: 10.1200/OP.22.00037

FIG 2.

FIG 2.

Hispanic patient representation in randomized investigator-initiated radiation oncology clinical trials opened in the MSK Cancer Alliance (n = 3) compared with those open only at MSK (non-Alliance, n = 3). Proportions of Hispanic representation in the US population (on the basis of the 2018 US Census) and on all radiation trials (n = 71)4 are included for reference. MSK, Memorial Sloan Kettering; RT, radiation therapy.